Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal
Journal of Chromatography B
Date
2021-02-01
Source
Crossref
DOI
10.1016/j.jchromb.2020.122486
PubMed
33485158
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:52:05 UTC
Metadata last checked
2026-08-09 08:28:50 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Indexed papers citing this DOI

Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake2026-05-23The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?2025-08-07Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications2025-03-07Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis2025-01-01Salience, sensemaking, and setting in psilocybin microdosing: Methodological lessons and preliminary findings of a mixed method qualitative study2024-09-26Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method2024-08-01In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin2024-04-29Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS)2024-03-01In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin2024-01-08Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin2024-01-06Development and validation of a sensitive LC-MS-MS method to quantify psilocin in authentic oral fluid samples2023-12-12A review of psilocybin: chemistry, clinical uses and future research directions2023-05-16Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects2022-12-01Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience2021-09-01

Related papers

No close related records were found yet.